Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Humacyte (HUMA) Other Non Operating Income (2024 - 2025)

Humacyte has reported Other Non Operating Income over the past 2 years, most recently at -$40.5 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$40.5 million for Q4 2025, down 5526.98% from a year ago — trailing twelve months through Dec 2025 was -$22.3 million (changed N/A YoY), and the annual figure for FY2025 was -$22.3 million, changed.
  • Other Non Operating Income for Q4 2025 was -$40.5 million at Humacyte, down from $4.0 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for HUMA hit a ceiling of $14.9 million in Q1 2025 and a floor of -$40.5 million in Q4 2025.